Literature DB >> 24115195

Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.

Cristina M Arce1, Benjamin A Goldstein, Aya A Mitani, Colin R Lenihan, Wolfgang C Winkelmayer.   

Abstract

BACKGROUND AND OBJECTIVES: Hispanic patients undergoing chronic dialysis are less likely to receive a kidney transplant compared with non-Hispanic whites. This study sought to elucidate disparities in the path to receipt of a deceased donor transplant between Hispanic and non-Hispanic whites. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using the US Renal Data System, 417,801 Caucasians who initiated dialysis between January 1, 1995 and December 31, 2007 with follow-up through 2008 were identified. This study investigated time from first dialysis to first kidney transplantation, time from first dialysis to waitlisting, and time from waitlisting to kidney transplantation. Multivariable Cox regression estimated cause-specific hazard ratios (HRCS) and subdistribution (competing risk) hazard ratios (HRSD) for Hispanics versus non-Hispanic whites.
RESULTS: Hispanics experienced lower adjusted rates of deceased donor kidney transplantation than non-Hispanic whites (HRCS, 0.77; 95% confidence interval [95% CI], 0.75 to 0.80) measured from dialysis initiation. No meaningful differences were found in time from dialysis initiation to placement on the transplant waitlist. Once waitlisted, Hispanics had lower adjusted rates of deceased donor kidney transplantation (HRCS, 0.66; 95% CI, 0.64 to 0.68), and the association attenuated once accounting for competing risks (HRSD, 0.79; 95% CI, 0.77 to 0.81). Additionally controlling for blood type and organ procurement organization further reduced the disparity (HRSD, 0.99; 95% CI, 0.96 to 1.02).
CONCLUSIONS: After accounting for geographic location and controlling for competing risks (e.g., Hispanic survival advantage), the disparity in access to deceased donor transplantation was markedly attenuated among Hispanics compared with non-Hispanic whites. To overcome the geographic disparities that Hispanics encounter in the path to transplantation, organ allocation policy revisions are needed to improve donor organ equity.

Entities:  

Mesh:

Year:  2013        PMID: 24115195      PMCID: PMC3848391          DOI: 10.2215/CJN.01560213

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?

Authors:  A M Epstein; J Z Ayanian; J H Keogh; S J Noonan; N Armistead; P D Cleary; J S Weissman; J A David-Kasdan; D Carlson; J Fuller; D Marsh; R M Conti
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

2.  Geographic differences in access to transplantation in the United States.

Authors:  Mary D Ellison; Leah B Edwards; Erick B Edwards; Clyde F Barker
Journal:  Transplantation       Date:  2003-11-15       Impact factor: 4.939

3.  Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease.

Authors:  Y N Hall; A M O'Hare; B A Young; E J Boyko; G M Chertow
Journal:  Am J Transplant       Date:  2008-09-19       Impact factor: 8.086

4.  Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.

Authors:  Y Hata; J M Cecka; S Takemoto; M Ozawa; Y W Cho; P I Terasaki
Journal:  Transplantation       Date:  1998-01-27       Impact factor: 4.939

5.  Predicting treatment costs and life expectancy for end-stage renal disease.

Authors:  P V Stange; A T Sumner
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

Review 6.  Racial equity in renal transplantation. The disparate impact of HLA-based allocation.

Authors:  R S Gaston; I Ayres; L G Dooley; A G Diethelm
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

7.  Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation.

Authors:  A K Mathur; V B Ashby; R L Sands; R A Wolfe
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

8.  Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race.

Authors:  Bhamidipati V R Murthy; Donald A Molony; Austin G Stack
Journal:  J Am Soc Nephrol       Date:  2005-01-26       Impact factor: 10.121

9.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

Authors:  F K Port; R A Wolfe; E A Mauger; D P Berling; K Jiang
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

10.  Access to renal transplantation among American Indians and Hispanics.

Authors:  Thomas D Sequist; Andrew S Narva; Sharon K Stiles; Shelley K Karp; Alan Cass; John Z Ayanian
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

View more
  27 in total

1.  The Other Half of Informed Consent: Transplant Education Practices in Dialysis Centers.

Authors:  Lauren M Kucirka; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 8.237

2.  Factors leading to the discard of deceased donor kidneys in the United States.

Authors:  Sumit Mohan; Mariana C Chiles; Rachel E Patzer; Stephen O Pastan; S Ali Husain; Dustin J Carpenter; Geoffrey K Dube; R John Crew; Lloyd E Ratner; David J Cohen
Journal:  Kidney Int       Date:  2018-05-05       Impact factor: 10.612

Review 3.  The promise of organ and tissue preservation to transform medicine.

Authors:  Sebastian Giwa; Jedediah K Lewis; Luis Alvarez; Robert Langer; Alvin E Roth; George M Church; James F Markmann; David H Sachs; Anil Chandraker; Jason A Wertheim; Martine Rothblatt; Edward S Boyden; Elling Eidbo; W P Andrew Lee; Bohdan Pomahac; Gerald Brandacher; David M Weinstock; Gloria Elliott; David Nelson; Jason P Acker; Korkut Uygun; Boris Schmalz; Brad P Weegman; Alessandro Tocchio; Greg M Fahy; Kenneth B Storey; Boris Rubinsky; John Bischof; Janet A W Elliott; Teresa K Woodruff; G John Morris; Utkan Demirci; Kelvin G M Brockbank; Erik J Woods; Robert N Ben; John G Baust; Dayong Gao; Barry Fuller; Yoed Rabin; David C Kravitz; Michael J Taylor; Mehmet Toner
Journal:  Nat Biotechnol       Date:  2017-06-07       Impact factor: 54.908

4.  Outcomes of Deceased Donor Kidney Offers to Patients at the Top of the Waiting List.

Authors:  Anne M Huml; Jeffrey M Albert; J Daryl Thornton; Ashwini R Sehgal
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-27       Impact factor: 8.237

Review 5.  CKD and ESRD in US Hispanics.

Authors:  Nisa Desai; Claudia M Lora; James P Lash; Ana C Ricardo
Journal:  Am J Kidney Dis       Date:  2018-04-13       Impact factor: 8.860

6.  Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Elaine Ku; Wei Yang; Charles E McCulloch; Harold I Feldman; Alan S Go; James Lash; Nisha Bansal; Jiang He; Ed Horwitz; Ana C Ricardo; Tariq Shafi; James Sondheimer; Raymond R Townsend; Sushrut S Waikar; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

7.  Racial and Ethnic Disparities in Survival of Children with ESRD.

Authors:  Elaine Ku; Charles E McCulloch; Barbara A Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2016-12-29       Impact factor: 10.121

8.  Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.

Authors:  Michelle M O'Shaughnessy; Maria E Montez-Rath; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2015-11-25       Impact factor: 5.992

9.  Improving Access to Kidney Transplantation: Referral Is Not Enough.

Authors:  Lauren M Kucirka; Tanjala S Purnell; Dorry L Segev
Journal:  JAMA       Date:  2015-08-11       Impact factor: 56.272

10.  Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.

Authors:  Rachel E Patzer; Laura C Plantinga; Sudeshna Paul; Jennifer Gander; Jenna Krisher; Leighann Sauls; Eric M Gibney; Laura Mulloy; Stephen O Pastan
Journal:  JAMA       Date:  2015-08-11       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.